Myungminhwan

Myungminhwan

Regular price $249.00 Sale price $199.00
/
Myungminhwan
 
Myungminhwan Packaging
Myungminhwan
Myungminhwan is the entry tier variant of the Myungmin series. It is ideal for those who are at the early onset of their dementia or Alzheimer's prognosis. It is a specially formulated herbal supplement that is produced under a carefully controlled enrichment process in an advanced FDA-compliant and registered manufacturing facility and prepared in a distinctly traditional Korean form of small bead-size chewable balls. Specially blended in small balls for easier consumption, it too provides all the cognitive and memory benefits of the Myungmin series in a reduced concentration and economical price point.
 
The disease that people today
 fear
the most is
 dementia
Myungmin
 is the answer
 
Myungmin is the answer to fight back against dementia
 
 
1. Myungmin is a patented treatment for dementia. Its safety and efficacy has been rigorously validated through numerous clinical trials.
2. Not getting grades consistent with the time spent studying? For improving memory and concentration, look no further!
3. Derived from wholly natural compounds, there is no concern for toxicity. Numerous individuals are currently taking Myungmin in their daily lives.
4. No abnormalities observed in blood tests. No negative side effects such as nausea, indigestion, vomiting or diarrhea.
 
 
Myungminhwan Packaging
Fight Against Alzheimer's
First To Reach 3rd Phase Clinical Trial In Korea
Alzheimer treatment Myungmin has been tested in nonclinical and clinical studies in both animals and humans. The results show increases in brain derived neurotrophics factor (BDNF) that promotes neurogenesis, substantial increases in the regeneration of brain cells in the hippocampus involved in learning and memory, and confirmed the significant improvements in cognitive ability in the studies conducted.
 
 
Myungminhwan Packaging
Myungminhwan Packaging
 
What is dementia?
 
What is dementia?
Dementia is a set of symptoms related to brain function that shows as impairment in memory, linguistics abilities, temporal and spatial understanding, judgment and abstract thinking abilities which negatively impact one's ability to function and carry out everyday activities. It results in a tremendous strain in the daily life of the one afflicted and is detrimental to their relations with friends, family and caregivers around them. Alzheimer's is the most common cause of dementia, accounting for 60-70% of the cases of dementia worldwide.
 
 
A normal functioning brain
A brain atrophied by Alzheimer's
 
 
Types of Dementia
Types of dementia and their distribution
Source: Ministry of Health and Welfare, 2012
Severity of Dementia
Cognitive disorder and behavioral disorder
(linguistic ability, visuospatial ability, task execution, calculating numbers, emotion and personality, short-term / long-term memory loss)
Source: Ministry of Health and Welfare, 2012
Severity of Dementia
Dementia patients by age groups (from 65 years old or older)
Source: National Institute of Dementia, 2017
 
 
Symptoms from the progression of dementia
Memory Loss Unable to remember any recent events
Language Impairment Cannot recall words or names of people
Perception of Time No sense of date or time
Situational Awareness Constantly losing sense of direction, getting lost
Loss of Dexterity Inability to use simple household devices and tools
Behavioral changes from progression of dementia
Personality Change Increase in aggression or stubbornness
Depression Exhibiting depression and generally appearing agitated
Restlessness Unable to sit still or exhibiting unintentional movement
Hallucinations Hearing or seeing objects or people that are not really there
Delusions Claiming personal property has been stolen by others
Indifference General apathy and lack of interest in doing anything
 
 
Causes of dementia and drug treatments
1. Accumulation of beta-amyloid proteins in the brain that clump together
2. Inflammatory response to tau proteins, oxidation damage, vascular tissues, etc.
3. Other forms of nerve damage
 
 
Product Name Drug Compound Usage/Dosage Active Mechanism Side-Effects
Razadyne tablet (4, 8mg) Razadyne PR SR capsule (8, 16, 24mg) Galantamine 2 times/day for 4 weeks, 4 mg/dosage; 2 times/day after 4 weeks, 8 mg/dosage (maximum dosage of 24mg/day) Acetylcholinesterase (AChE) inhibitor Nausea, vomiting, diarrhea, stomachache, indigestion, loss of appetite, fatigue, dizziness, headache, drowsiness, weight loss
Exelon capsule (1.5, 3, 4.5, 6mg) Rivastigmine 2 times/day, 1.5mg/dosage; Titration up to 3, 6, 9, 12mg/day in 2-week intervals (maximum dosage of 12mg/day) Acetylcholinesterase (AChE) inhibitor Nausea, vomiting, diarrhea, stomachache, loss of appetite, dizziness, agitation
Aricept tablet (5, 10, 23mg) Donepezil 5mg/dosage once a day (for over 4 weeks); maintain a 5-10mg dosage per day Acetylcholinesterase (AChE) inhibitor Nausea, vomiting, muscle cramps, fatigue, vertigo, diarrhea
Namenda tablet (10mg) Namenda oral drops (10mg/g) Memantine 10mg/day; gradually increase dosage by 10mg/day in 1 week intervals; spread dosages of 20-30mg evenly over the course of the day (maximum dosage 60mg/day) NDMA receptor antagonist Dizziness, confusion, sleep disorder, agitation, fatigue, headache, constipation
Source: Seoul National University, Bundang Hospital, Phamacology Department, 2005
 
Myungmin Pharmacological Effects in Animals
 
Preclinical Animal Studies
Results of Micro PET/CT imaging in mouse model of Alzheimer's type dementia, research in conjunction with the Korea Atomic Energy Research Institute
 
 
Myungmin ChAT measurement results
ChAT measurement results in CA1 and CA3 regions
Myungmin PKC immunoreactive neuron activity measurements
PKC immunoreactive neuron activity measurements
Myungmin glucose metabolism in brain
Excerpts from the white paper showing glucose metabolism in the brain by Micro PET/CT imaging. Higher metabolism and the resulting brain activity is denoted by the deeper shades of red.
 
Myungmin Pharmacological Effects in Humans
 
Clinical Human Studies
Results of IQ tests and P300 wave measurements done on students in the Department of Psychology, Korea University. Placebo and Myungmin were administred daily over the course of 6 weeks, tests were conducted before and after the 6 week trial.
 
 
Myungmin IQ test results
Korean IQ equivalent test scores
(Placebo vs Myungmin)
Myungmin P300a latency measurements
P300a latency response time
(Placebo vs Myungmin)
 
 
Myungmin P300b latency measurements
P300b latency response time
(Placebo vs Myungmin)
❖ Study Results
The study on the students at Korea University between the placebo group and the Myungmin group show an improvement in IQ scores and a shorter latency response time in P300a and P300b wave measurements among those in the Myungmin group.
**P300 wave is an event related potential elicited in the process of decision making. It is an endogenous potential, meaning it is one's reaction to a stimulus, not connected to physical attributes of a stimulus. P300a and P300b values are measured by EEG
Lower value is better, indicating quicker reaction times
 
 
Selected as a Study from the Ministry of Health and Welfare
Research Period: June 2011 - May 2013
IRB of 4 Institutions: Seoul St Mary's Hospital, Seoul St. Vincent Hospital, Ilsan Hospital, Kyunghee University Medical Center
 
 
Myungmin PKC immunoreactive neuron activity measurements
❖ Study Results
The 4 institutions conducted clinical trials on 125 patients and as with previous preclinical animal studies, clinical trials and research results, significant improvements were observed in the Myungmin test group. Clinically significant safety issues and side-effects were not observed.
 
Myungmin Safety Testing Standards
 
Testing Authority: Ewha Womans University College of Pharmacy
Tests were conducted on Myungmin to ensure purity of the individual compounds, including tests for the detection of heavy metals and high performance liquid chromatography to ensure no other foreign substances contaminate the product.
 
 
Myungmin Individual Compound Purity Test
Test of the purity of the individual compounds
Myungmin Heavy Metal Test Panel
Test for presence of Heavy Metals
Myungmin High Performance Liquid Chromatography Test
Test for presence of foreign contaminants
 
 
Myungmin Compound Stability Test
Test to determine long term stability of active compounds
 
 
Myungmin Arsenic Test
Test to determine arsenic levels
Myungmin Foreign Microbial Content Test
Test to detect contaminant microbes
 
Myungmin Phase 3 (Final Phase) Clinical Trials
 
On September 27, 2018, Mediforum has received approval for the phase 3 clinical trial for dementia treatment, the first to reach such milestone in Korea.
 
 
As featured on YTN bizlife TV News Segment
 
Myungmin Patent
 
Mediforum has been issued a patent by the Korean Intellectual Property Office
 
 
Myungmin Korean Patent
Myungmin is an herbal medicine with proven safety and efficacy. It has an excellent effect on the neurological functions of seni and improvements to the studying and concentration of students and professionals.

It has undergone exhaustive tests in safety, including tests for compound purity, arsenic and heavy metals, contaminants and foreign microbes. SOP and GMP policies are in place to ensure quality and consistency in production.

The lack of serious negative side-effects and impact on blood physiology and organs have been thoroughly investigated and documented with each and every clinical trial.
Patent Issued by KIPO
 
Fight Against Alzheimer's
 
Fighting Alzheimer's with lack of side-effects
 
 
As featured on YTN News TV Segment
Selected quotes from the video segment:
"In mouse model clinical trials, there was a 20% reduction in the amount of time to do a task in the Myungmin test group compared to the control group."

"There was a reduction of 50% in beta amyloid plaque among the group that took Myungmin."

"In addition, with the use of all natural traditional herbal compounds, there were no negative side-effects exhibited when taking Myungmin."

"It has been confirmed to be effective not only to elderly seniors, but has shown efficacy in younger healthy individuals and enhanced physical strength to those consuming it."
 

Why choose Mediforum?

Safety above all else

Our products are rigorously tested for safety and efficacy. Our supplements are regularly tested for purity of the individual compounds, including tests for the detection of heavy metals, microbial contamination and high performance liquid chromatography to ensure no other foreign substances contaminate the product.

Efficacy in its use

No matter how safe the products are, there would be no point in taking it if it didn't produce results. We conduct a multitude of trials, both in a clinical and nonclinical setting, in both animals and humans to determine the efficacy of the supplements and medicine we develop. We work with global CROs to conduct clinical trials and validate them to international pharmaceutical standards.

We are Mediforum


Featured on various news outlets and with a multitude of international
certifications under our belt, we are committed to bring out the best
that you can be. Trusted by thousands of customers across the world.

Featured Media and News Outlets

Testimonials

My son was always fatigued so we gave BrainOne a shot, within just days he said he felt much better. I didn't think much of it until I caught a cold, BrainOne helped me get over it within days! I've never felt better!

H.Y. Lee

My mother has mild Alzheimer's and taking Aricept made things much worse. Upon taking Myungminwon, her condition improved drastically. We hadn't seen her smile in months, I only wish we had heard of this sooner!

Rick Chang